Literature DB >> 6755781

Manipulation of host resistance in cancer therapy.

R W Baldwin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6755781     DOI: 10.1007/bf00199791

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  65 in total

Review 1.  Immunotherapy from malignant disease.

Authors:  J E Goodnight; D L Morton
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

Review 2.  Antitumor activity of Corynebacterium parvum.

Authors:  L Milas; M T Scott
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

3.  Controlled trial of active immunotherapy in management of stage IIB malignant melanoma.

Authors:  M B McIllmurray; M J Embleton; W G Reeves; M J Langman; M Deane
Journal:  Br Med J       Date:  1977-02-26

Review 4.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

5.  Immunology of spontaneously arising rat mammary adenocarcinomas.

Authors:  R W Baldwin; M J Embleton
Journal:  Int J Cancer       Date:  1969-07-15       Impact factor: 7.396

Review 6.  Mechanisms of immunity in cancer.

Authors:  R W Baldwin
Journal:  Pathobiol Annu       Date:  1981

7.  Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.

Authors:  S H Lee; S Kelley; H Chiu; N Stebbing
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

8.  Production of human hybridomas secreting antibodies to measles virus.

Authors:  C M Croce; A Linnenbach; W Hall; Z Steplewski; H Koprowski
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

9.  Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.

Authors:  D O Adams; W J Johnson; P A Marino
Journal:  Fed Proc       Date:  1982-04

10.  Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.

Authors:  O Eremin; R R Coombs; J Ashby
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

View more
  3 in total

1.  Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung carcinoma.

Authors:  G Sava; L Perissin; S Zorzet
Journal:  Clin Exp Metastasis       Date:  1988 May-Jun       Impact factor: 5.150

2.  Antitumor and antimetastatic activity of the immunoadjuvant peptidoglycan monomer PGM in mice bearing MCa mammary carcinoma.

Authors:  G Sava; J Tomasic; I Hrsak
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 3.  Enhanced immune response and antitumor immunity with combinations of biological response modifiers.

Authors:  E Garaci; A Mastino; C Favalli
Journal:  Bull N Y Acad Med       Date:  1989-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.